GleamWall
中文EN

TNBI Tanke Biosciences Corp

Grain Mill Products · OTC · SEC CIK 1452011 · Fiscal year ends 12/31

Financial factors as of 2013-09-30 (2013Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-19.5%
TTM net income YoY-164.1%
TTM EPS YoY-165.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin32.3%
Operating margin-0.2%
Net margin-7.1%
FCF margin-27.3%
EBITDA margin2.1%

Returns

ROE-10.2%
ROA-5.7%
ROIC (approx.)-0.4%
Asset turnover0.80x

Leverage & solvency

Liabilities / assets45.5%
Debt / equity0.12x
Current ratio1.61x
Interest coverage-0.10x

Cash quality & payout

Operating cash flow / net income2.30x
Accruals ratio7.4%
Payout ratio—
Capex / revenue10.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2013Q32013-09-302013Q22013-06-302013Q12013-03-312012Q4*2012-12-312012Q32012-09-302012Q22012-06-302012Q12012-03-312011Q4*2011-12-31
Income statement
Revenue$6.04M$5.58M$4.66M$6.68M$9.91M$7.43M$4.54M$6.65M
Cost of revenue$4.35M$3.75M$2.99M$4.45M$6.52M$4.69M$2.95M$4.33M
Gross profit$1.69M$1.82M$1.67M$2.23M$3.39M$2.74M$1.59M$2.33M
R&D expense———$182,243————
SG&A expense$1.36M$997,469$981,590$776,343$574,092$680,232$541,004$616,485
Operating income-$530,338$149,690-$39,893$363,273$2.18M$1.50M$488,508$1.02M
Interest expense-$46,575$39,376$215,059$387,496$316,422$368,782$373,087-$135,661
Pretax income-$339,851$169,194-$646,745-$620,189$1.19M$585,916-$554,281$2.16M
Income tax-$26,907$53,512$32,099$178,886$222,513$313,502$116,696$175,816
Net income-$302,084$118,164-$676,329-$780,316$968,632$272,414-$670,977$1.99M
EBITDA-$463,001$201,929$139,993$595,436$2.20M$1.51M$612,310$1.29M
EPS (basic)-0.020.01-0.05—0.070.02-0.05—
EPS (diluted)-0.020.01-0.05—0.070.02-0.05—
Weighted avg. shares (diluted)13.32M13.32M13.32M—13.32M13.32M13.32M—
Balance sheet
Cash & equivalents$5.05M$4.72M$5.59M$6.17M$11.04M$10.03M$7.64M$7.70M
Receivables$2.76M$2.38M$1.85M$1.99M$2.28M$1.82M$1.72M$1.92M
Inventory$1.65M$2.08M$1.40M$1.41M$1.64M$1.26M$1.36M$1.19M
Current assets$19.70M$21.92M$21.74M$22.37M$22.20M$20.65M$18.37M$18.91M
PP&E, net$6.34M$5.26M$5.16M$4.81M$4.92M$4.87M$4.88M$4.77M
Intangibles$1.15M$1.19M$1.20M$1.24M$1.27M$1.32M$844,573$838,089
Total assets$28.81M$29.47M$28.66M$28.85M$28.84M$27.29M$24.45M$24.89M
Current liabilities$12.24M$12.70M$11.79M$12.10M$11.16M$9.77M$8.82M$3.55M
Short-term debt$1.14M$1.29M$796,950$1.27M$1.34M$793,817$1.11M$785,456
Long-term debt$732,649$808,848$1.43M$792,567$948,391$1.59M$0$628,365
Total debt$1.87M$2.10M$2.23M$2.06M$2.29M$2.38M$1.11M$1.41M
Total liabilities$13.10M$13.59M$13.28M$12.93M$12.31M$11.62M$9.16M$9.03M
Shareholders' equity$15.56M$15.71M$15.21M$15.75M$16.53M$15.67M$15.30M$15.85M
Net debt-$3.18M-$2.62M-$3.35M-$4.11M-$8.75M-$7.65M-$6.53M-$6.29M
Shares outstanding13.32M13.32M13.32M13.32M13.32M13.32M13.32M13.32M
Cash flow statement
Operating cash flow$1.61M-$134,582-$101,190-$5.16M$1.55M$1.77M$508,675$731,202
Capital expenditure$1.07M$613,496$746,033$56,439$411,576$194,713$193,633$224,386
Free cash flow$538,076-$748,078-$847,223-$5.21M$1.14M$1.57M$315,042$506,816
Investing cash flow-$1.08M-$645,210-$746,033$257,973-$394,306-$866,457-$380,145-$2.11M
Financing cash flow-$241,200-$159,200$230,199$75,532-$44,933$1.40M-$304,738-$3.07M
Depreciation & amortization$67,337$52,239$179,886$232,163$16,642$14,763$123,802$274,450
Stock-based compensation——————$0—

Free plan shows the latest 8 periods; Pro shows all 14 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.